Page last updated: 2024-08-21

malondialdehyde and Depressive Disorder, Major

malondialdehyde has been researched along with Depressive Disorder, Major in 18 studies

Research

Studies (18)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (16.67)29.6817
2010's12 (66.67)24.3611
2020's3 (16.67)2.80

Authors

AuthorsStudies
Alvarez-Mon, M; Alvarez-Mon, MA; Fraile-Martinez, O; García-Montero, C; Gomez-Lahoz, AM; Gutierrez-Rojas, L; Lahera, G; Molero, P; Monserrat, J; Ortega, MA; Quintero, J; Rodriguez-Jimenez, R1
Chai, Y; Chen, J; Chen, YW; Cheng, Y; Liu, H; Liu, LL; Liu, QS1
Esmaeili, A; Jafari, S; Khalili-Tanha, G; Kooshkaki, O; Mobasheri, L; Sarab, GA; Shokouhifar, A; Taene, A1
Jiang, MD; Wang, JL; Wang, YF; Zheng, Y1
de Almeida, EA; de Araújo Filho, GM; de Jesus Brait, B; Furlan, AER; Lopes, AM; Marques, LHN; Martins, DP; Oliveira, CIF; Souza, DRS1
Barbosa, DS; Bonifacio, KL; Carvalho, AF; Maes, M; Moreira, EG; Morelli, NR; Nunes, SOV; St Stoyanov, D; Vargas, HO1
Chen, H; Cong, R; Hu, K; Huang, Q; Liu, Q; Wang, Z; Xiao, L; Xiong, W; Zhang, S1
Cittadin-Soares, Eda C; Danielski, LG; de Mello, AH; Florentino, D; Fortunato, JJ; Gassenferth, A; Petronilho, F; Quevedo, J; Rezin, GT; Schraiber, Rde B; Souza, Lda R1
Costa E Silva, J; Kalia, M1
Ma, SP; Qu, R; Yang, SJ; Yin, ZJ; Yu, HY1
Camkurt, MA; Fındıklı, E; İzci, F; Kurutaş, EB; Tuman, TC1
Borchers, CH; Han, J; Levitt, A; Lin, K; Sobsey, CA; Swardfager, W1
Bahn, S; Bernstein, HG; Brigadski, T; Dobrowolny, H; Frodl, T; Guest, PC; Isermann, B; Jordan, W; Lessmann, V; Pilz, J; Rodenbeck, A; Schiltz, K; Schwedhelm, E; Steiner, J; Tumani, H; Wiltfang, J1
Kirhan, E; Kirli, S; Kotan, VO; Ozkaya, G; Sarandol, E1
Ciobica, A; Stefanescu, C1
Dirican, M; Eker, SS; Hizli, BZ; Karaagac, EU; Kirli, S; Sarandol, A; Sarandol, E1
Eker, SS; Erdinc, S; Kirli, S; Sarandol, A; Sarandol, E; Vatansever, E1
Bekaroğlu, M; Bilici, M; Değer, O; Efe, H; Köroğlu, MA; Uydu, HA1

Reviews

1 review(s) available for malondialdehyde and Depressive Disorder, Major

ArticleYear
Biomarkers of psychiatric diseases: current status and future prospects.
    Metabolism: clinical and experimental, 2015, Volume: 64, Issue:3 Suppl 1

    Topics: Acetyltransferases; Alzheimer Disease; Biomarkers; Bipolar Disorder; Brain; Brain-Derived Neurotrophic Factor; C-Reactive Protein; Cytokines; Depressive Disorder, Major; Dopamine; gamma-Aminobutyric Acid; History, 20th Century; Humans; Isoprostanes; Malondialdehyde; Mental Disorders; Mood Disorders; Neopterin; Neurofibrillary Tangles; S100 Calcium Binding Protein beta Subunit; Schizophrenia; Suicidal Ideation

2015

Trials

1 trial(s) available for malondialdehyde and Depressive Disorder, Major

ArticleYear
Oxidation of apolipoprotein B-containing lipoproteins and serum paraoxonase/arylesterase activities in major depressive disorder.
    Progress in neuro-psychopharmacology & biological psychiatry, 2006, Aug-30, Volume: 30, Issue:6

    Topics: Adult; Antidepressive Agents; Apolipoproteins B; Aryldialkylphosphatase; C-Reactive Protein; Carboxylic Ester Hydrolases; Cholesterol; Cholesterol, HDL; Depressive Disorder, Major; Female; Homocysteine; Humans; Lipoproteins; Male; Malondialdehyde; Middle Aged; Oxidation-Reduction; Phenotype; Psychiatric Status Rating Scales; Triglycerides

2006

Other Studies

16 other study(ies) available for malondialdehyde and Depressive Disorder, Major

ArticleYear
Differential malondialdehyde (MDA) detection in plasma samples of patients with major depressive disorder (MDD): A potential biomarker.
    The Journal of international medical research, 2022, Volume: 50, Issue:5

    Topics: Biomarkers; Cross-Sectional Studies; Depressive Disorder, Major; Humans; Malondialdehyde; Prospective Studies

2022
Muscone with Attenuation of Neuroinflammation and Oxidative Stress Exerts Antidepressant-Like Effect in Mouse Model of Chronic Restraint Stress.
    Oxidative medicine and cellular longevity, 2022, Volume: 2022

    Topics: Animals; Antidepressive Agents; Behavior, Animal; Cyclooxygenase 2; Cycloparaffins; Depression; Depressive Disorder, Major; Doublecortin Domain Proteins; Glutathione Peroxidase; Hippocampus; Inflammation Mediators; Interleukin-1; Interleukin-10; Interleukin-4; Interleukin-6; Malondialdehyde; Mice; Neuroinflammatory Diseases; Neuroprotective Agents; Oxidative Stress; Stress, Psychological; Superoxide Dismutase; Tumor Necrosis Factor-alpha

2022
The Association of Major Depressive Disorder with Activation of NLRP3 Inflammasome, Lipid Peroxidation, and Total Antioxidant Capacity.
    Journal of molecular neuroscience : MN, 2020, Volume: 70, Issue:1

    Topics: Adult; Biomarkers; Caspase 1; Cells, Cultured; Depressive Disorder, Major; Female; Humans; Leukocytes, Mononuclear; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; NLR Family, Pyrin Domain-Containing 3 Protein

2020
Drug induces depression-like phenotypes and alters gene expression profiles in Drosophila.
    Brain research bulletin, 2017, Volume: 132

    Topics: Animals; Chlorpromazine; Depressive Disorder, Major; Disease Models, Animal; Dose-Response Relationship, Drug; Drosophila melanogaster; Eating; Female; Gene Expression; Levodopa; Male; Malondialdehyde; Maternal Exposure; Paternal Exposure; Serotonin; Sexual Behavior, Animal; Superoxide Dismutase

2017
Oxidative stress in patients with refractory temporal lobe epilepsy and mesial temporal sclerosis: Possible association with major depressive disorder?
    Epilepsy & behavior : E&B, 2018, Volume: 80

    Topics: Adult; Case-Control Studies; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Epilepsy, Temporal Lobe; Female; Humans; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Sclerosis; Temporal Lobe

2018
Generalized Anxiety Disorder (GAD) and Comorbid Major Depression with GAD Are Characterized by Enhanced Nitro-oxidative Stress, Increased Lipid Peroxidation, and Lowered Lipid-Associated Antioxidant Defenses.
    Neurotoxicity research, 2018, Volume: 34, Issue:3

    Topics: Adult; Advanced Oxidation Protein Products; Analysis of Variance; Anxiety Disorders; Aryldialkylphosphatase; Body Mass Index; Depressive Disorder, Major; Female; Humans; Lipid Peroxidation; Lipoproteins, HDL; Male; Malondialdehyde; Middle Aged; Nitric Oxide; Oxidative Stress; Uric Acid; Young Adult

2018
The Chinese Herbal Formula PAPZ Ameliorates Behavioral Abnormalities in Depressive Mice.
    Nutrients, 2019, Apr-16, Volume: 11, Issue:4

    Topics: Angelica sinensis; Animals; Antidepressive Agents; Antioxidants; Behavior, Animal; Brain-Derived Neurotrophic Factor; Corticosterone; Depression; Depressive Disorder, Major; Disease Models, Animal; Drugs, Chinese Herbal; Hippocampus; Magnoliopsida; Male; Malondialdehyde; Mice, Inbred C57BL; Panax; Phytotherapy; Polygala; Superoxide Dismutase; Ziziphus

2019
Effects of omega-3 on behavioral and biochemical parameters in rats submitted to chronic mild stress.
    Metabolic brain disease, 2014, Volume: 29, Issue:3

    Topics: Anhedonia; Animals; Behavior, Animal; Body Weight; Brain; Depressive Disorder, Major; Disease Models, Animal; Electron Transport Complex I; Fatty Acids, Omega-3; Male; Malondialdehyde; Oxidative Stress; Rats; Rats, Wistar; Stress, Psychological

2014
Baicalin Reverses Depressive-Like Behaviours and Regulates Apoptotic Signalling Induced by Olfactory Bulbectomy.
    Phytotherapy research : PTR, 2016, Volume: 30, Issue:3

    Topics: Animals; Antidepressive Agents; Apoptosis; Apoptotic Protease-Activating Factor 1; Behavior, Animal; Caspases; Depression; Depressive Disorder, Major; Flavonoids; Glutathione Peroxidase; Hippocampus; Male; Malondialdehyde; Olfactory Bulb; Oxidative Stress; Phytotherapy; Plant Extracts; Rats, Wistar; Scutellaria; Signal Transduction; Superoxide Dismutase; Synaptophysin

2016
Evaluation of malondialdehyde, superoxide dismutase and catalase activity and their diagnostic value in drug naïve, first episode, non-smoker major depression patients and healthy controls.
    Psychiatry research, 2016, Apr-30, Volume: 238

    Topics: Adult; Antioxidants; Biomarkers; Case-Control Studies; Catalase; Depressive Disorder, Major; Female; Humans; Male; Malondialdehyde; Middle Aged; Oxidation-Reduction; Oxidative Stress; Predictive Value of Tests; Superoxide Dismutase

2016
Development and evaluation of a liquid chromatography-mass spectrometry method for rapid, accurate quantitation of malondialdehyde in human plasma.
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2016, Sep-01, Volume: 1029-1030

    Topics: Chromatography, High Pressure Liquid; Depressive Disorder, Major; Female; Humans; Limit of Detection; Male; Malondialdehyde; Phenylhydrazines; Pilot Projects; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry

2016
Oxidative stress in drug-naïve first episode patients with schizophrenia and major depression: effects of disease acuity and potential confounders.
    European archives of psychiatry and clinical neuroscience, 2018, Volume: 268, Issue:2

    Topics: Adult; Depressive Disorder, Major; Dinoprost; Female; Follow-Up Studies; Glutathione Transferase; Humans; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Psychiatric Status Rating Scales; Schizophrenia; Statistics, Nonparametric; Superoxide Dismutase

2018
Effects of long-term antidepressant treatment on oxidative status in major depressive disorder: a 24-week follow-up study.
    Progress in neuro-psychopharmacology & biological psychiatry, 2011, Jul-01, Volume: 35, Issue:5

    Topics: Adult; Antidepressive Agents; Antioxidants; Apolipoproteins; Aryldialkylphosphatase; Blood Cell Count; Body Mass Index; Carboxylic Ester Hydrolases; Cardiovascular Diseases; Depressive Disorder, Major; Female; Follow-Up Studies; Hormones; Humans; Lipids; Liver Function Tests; Long-Term Care; Male; Malondialdehyde; Oxidative Stress; Psychiatric Status Rating Scales; Risk Factors; Superoxide Dismutase; Young Adult

2011
The relevance of oxidative stress status in first episode and recurrent depression.
    Journal of affective disorders, 2012, Dec-20, Volume: 143, Issue:1-3

    Topics: Adult; Aged; Antidepressive Agents; Antioxidants; Biomarkers; Case-Control Studies; Depression; Depressive Disorder, Major; Female; Glutathione Peroxidase; Humans; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Recurrence; Superoxide Dismutase

2012
Major depressive disorder is accompanied with oxidative stress: short-term antidepressant treatment does not alter oxidative-antioxidative systems.
    Human psychopharmacology, 2007, Volume: 22, Issue:2

    Topics: Adult; Antidepressive Agents; Antioxidants; Ascorbic Acid; Carotenoids; Depressive Disorder, Major; Erythrocytes; Female; Glutathione Peroxidase; Humans; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Superoxide Dismutase; Time Factors; Uric Acid; Vitamin E

2007
Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments.
    Journal of affective disorders, 2001, Volume: 64, Issue:1

    Topics: Adult; Age Factors; Antidepressive Agents; Catalase; Cholesterol; Depressive Disorder, Major; Erythrocyte Count; Female; Glutathione Peroxidase; Glutathione Reductase; Humans; Lipid Peroxidation; Male; Malondialdehyde; Reactive Oxygen Species; Triglycerides

2001